首页> 美国卫生研究院文献>Journal of Cellular and Molecular Medicine >Low level laser irradiation precondition to create friendly milieu of infarcted myocardium and enhance early survival of transplanted bone marrow cells
【2h】

Low level laser irradiation precondition to create friendly milieu of infarcted myocardium and enhance early survival of transplanted bone marrow cells

机译:低水平激光照射的先决条件是创造友好的梗死心肌环境并提高移植骨髓细胞的早期存活率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We suggested that low-level laser irradiation (LLLI) precondition prior to cell transplantation might remodel the hostile milieu of infarcted myocardium and subsequently enhance early survival and therapeutic potential of implanted bone marrow mesenchymal stem cells (BMSCs). Therefore, in this study we wanted to address: (1) whether LLLI pre-treatment change the local cardiac micro-environment after myocardial infarction (MI) and (2) whether the LLLI preconditions enhance early cell survival and thus improve therapeutic angiogenesis and heart function. MI was induced by left anterior descending artery ligation in female rats. A 635 nm, 5 mW diode laser was performed with energy density of 0.96 J/cm2 for 150 sec. for the purpose of myocardial precondition. Three weeks later, qualified rats were randomly received with LLLI precondition (n= 26) or without LLLI precondition (n= 27) for LLLI precondition study. Rats that received thoracotomy without coronary ligation were served as sham group (n= 24). In the cell survival study, rats were randomly divided into 4 groups: serum-free culture media injection (n= 8), LLLI precondition and culture media injection (n= 8), 2 million male BMSCs transplantation without LLLI pre-treatment (n= 26) and 2 million male BMSCs transplantation with LLLI precondition (n= 25) group, respectively. Vascular endothelial growth factor (VEGF), glucose-regulated protein 78 (GRP78), superoxide dismutase (SOD) and malondialdehyde (MDA) in the infarcted myocardium were evaluated by Western blotting, real-time PCR and colorimetry, respectively, at 1 hr, 1 day and 1 week after laser irradiation. Cell survival was assayed with quantitative real-time PCR to identify Y chromosome gene and apoptosis was assayed with transferase-mediated dUTP end labelling staining. Capillary density, myogenic differentiation and left ventricular function were tested by immunohistochemistry and echocardiography, respectively, at 1 week. After LLLI precondition, increased VEGF and GRP78 expression, as well as the enhanced SOD activity and inhibited MDA production, was observed. Compared with BMSC transplantation and culture media injection group, although there was no difference in the improved heart function and myogenic differentiation, LLLI precondition significantly enhanced early cell survival rate by 2-fold, decreased the apoptotic percentage of implanted BMSCs in infarcted myocardium and thus increased the number of newly formed capillaries. Taken together, LLLI precondition could be a novel non-invasive approach for intraoperative cell transplantation to enhance cell early survival and therapeutic potential.
机译:我们建议在细胞移植之前进行低水平激光照射(LLLI)的先决条件可能会重塑梗死心肌的敌对环境,从而提高植入的骨髓间充质干细胞(BMSCs)的早期存活率和治疗潜力。因此,在这项研究中,我们想要解决:(1)LLLI预处理是否会改变心肌梗塞(MI)后的局部心脏微环境,以及(2)LLLI预处理是否能提高早期细胞存活率并从而改善治疗性血管生成和心脏功能。雌性大鼠左前降支结扎可诱发心肌梗死。用能量密度为0.96 J / cm 2 的635 nm,5 mW二极管激光器进行了150秒的发射。为了心肌的前提条件。三周后,将合格的大鼠随机接受LLLI前提条件(n = 26)或不使用LLLI前提条件(n = 27)进行LLLI前提条件研究。将未经冠状动脉结扎术的开胸大鼠作为假手术组(n = 24)。在细胞存活研究中,将大鼠随机分为4组:无血清培养基注射(n = 8),LLLI预处理和培养基注射(n = 8),200万只未经LLLI预处理的雄性BMSC移植(n = 26)和200万具LLLI前提条件(n = 25)的雄性BMSC移植。在1小时时,分别通过Western印迹,实时PCR和比色法评估梗塞心肌中的血管内皮生长因子(VEGF),葡萄糖调节蛋白78(GRP78),超氧化物歧化酶(SOD)和丙二醛(MDA),激光照射后1天1周。用定量实时PCR测定细胞存活以鉴定Y染色体基因,并用转移酶介导的dUTP末端标记染色测定细胞凋亡。 1周时分别通过免疫组织化学和超声心动图检查毛细血管密度,肌源性分化和左心室功能。 LLLI预处理后,观察到VEGF和GRP78表达增加,以及SOD活性增强和MDA生成抑制。与BMSC移植和培养基注射组相比,尽管LLLI预处理在改善心脏功能和生肌分化方面没有差异,但LLLI预处理可显着提高早期细胞存活率2倍,降低梗死心肌中植入BMSC的凋亡百分比,从而增加新形成的毛细管数。综上所述,LLLI前提条件可能是用于术中细胞移植以提高细胞早期存活率和治疗潜力的新型非侵入性方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号